Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Financial Results

Every financial results filing by a US-listed company that our alert engine sent, newest first.

4:08 PM ET 8-K
Financial Results Medallion Financial Corp MFIN

Medallion Financial Financial Results

Medallion Financial Corp. reported Q3 2026 net income of $2.4 million, down from $7.8 million in the prior year, primarily due to higher upfront credit loss provisions tied to significant loan growth. Total loan originations grew 41% year-over-year to $603.9 million, driven by strong performance in home improvement and recreation lending. Subsequent to the quarter end, the company authorized a new $40 million stock repurchase program.

Term
Q3 2026

“Our third quarter results further demonstrate the strength of our consumer lending platform. We continued to grow our loan portfolio, with total assets reaching a record level of more than $3.3 billion. During the quarter, recreation and home improvement loans increased 5% and 7%, respectively, from last quarter. They have grown 16% and 18% over the past twelve months. Total loan originations increased 41% year-over-year to $603.9 million. We are especially pleased with the growth in our home improvement loan origination volume, which grew by 145% in this quarter from last year.”

Andrew Murstein, President and Chief Executive Officer of Medallion Financial Corp.

“As we’ve said previously, growth at these levels requires us to recognize large upfront day-one provisions, which reduced earnings significantly during the quarter. While these provisions result in an immediate impact on reported earnings, they reflect the expansion of our loan portfolio and position us to generate increased earnings and shareholder value over time. These day-one provisions are a large part of the decrease in earnings this quarter from the prior year.”

Andrew Murstein, President and Chief Executive Officer of Medallion Financial Corp.
4:08 PM ET 10-Q
Financial Results Midland States Bancorp, Inc. MSBI

Midland States Bancorp Q3 2026 Results: Net Income $22.8M, Up 201.8% YoY

Midland States Bancorp reported a significant turnaround for the nine months ended September 30, 2026, with net income of $61.2 million compared to a net loss of $121.4 million in the prior year, which was impacted by a $154.0 million goodwill impairment. Total assets grew to $6.82 billion, driven by an increase in investment securities, while the company maintained a strong net interest income of $179.7 million.

Key figure
Net income $22.8M · +201.8% YoY
4:08 PM ET 8-K
Financial Results Illumina, Inc. ILMN

Illumina Financial Results

Illumina reported Q3 2026 revenue of $1.13 billion, up 4.2% year-over-year, driven by healthy clinical demand and robust NovaSeq X placements. Based on this momentum, the company raised its full-year 2026 revenue guidance to $4.64-$4.66 billion and non-GAAP EPS guidance to $5.40-$5.45.

“In the third quarter, healthy clinical demand and robust NovaSeq X placements drove results above our guidance. Based on continued momentum, we are raising our full year revenue and earnings guidance.”

Jacob Thaysen, Chief Executive Officer of Illumina

“As we continue to execute our strategy, our innovation is broadening the value of the Illumina ecosystem. Together with our customers, we are laying the foundation for AI to transform our understanding of human biology and improve patient outcomes.”

Jacob Thaysen, Chief Executive Officer of Illumina
4:08 PM ET 8-K
Financial Results Merit Medical Systems Inc MMSI

Merit Medical Systems Financial Results

Merit Medical Systems reported Q3 2026 financial results with 8.4% revenue growth and raised its full-year 2026 guidance. The company also disclosed the $45 million cash acquisition of Solo Pace, Inc., which was completed on October 13, 2026.

Counterparty
Solo Pace, Inc.

“Merit delivered third quarter financial results that exceeded the high end of our expectations, driven primarily by 9% organic, constant currency revenue growth, excluding the impact of a strategic divestiture.”

Martha G. Aronson, Merit’s President and CEO

“We have raised our 2026 revenue and non-GAAP earnings per share guidance to reflect the stronger-than-expected results over the first nine months of 2026 and remain confident in our team’s ability to execute, with attractive constant currency growth, improving profitability, and solid cash flow generation this year.”

Martha G. Aronson, Merit’s President and CEO
4:08 PM ET 8-K
Financial Results Financial Institutions Inc FISI

Financial Institutions Financial Results

Financial Institutions, Inc. reported Q3 2026 net income of $19.6 million, or $0.99 per diluted share, driven by 2.2% loan growth and 3.3% deposit growth. Net interest income reached a quarterly high of $54.3 million with a stable net interest margin of 3.70%. The company also repurchased 185,833 shares of common stock during the quarter at an average price of $40.92.

Term
Q3 2026

“Our third quarter results underscore the strength of our relationship-driven business model and our unwavering commitment to disciplined execution. Our commercial franchise continues to be the primary driver of loan growth and was supported by increases in consumer indirect and residential mortgage lending during the third quarter.”

Martin K. Birmingham, President and Chief Executive Officer

“Third quarter performance benefited from continued growth in average earning assets and effective balance sheet management, supporting a 3.70% net interest margin and a nearly 5% increase in net interest income from the prior year period.”

W. Jack Plants II, Chief Financial Officer and Treasurer
4:08 PM ET 8-K
Financial Results Starbucks Corp SBUX

Starbucks Financial Results

Starbucks reported Q4 fiscal 2026 results with global comparable coffeehouse sales up 7.2%, though consolidated net revenues fell 4% to $9.1 billion due to the conversion of China operations to a licensed model. GAAP EPS rose significantly to $0.59, and the company ended the fiscal year with 41,607 global coffeehouses.

Term
Q4 2026
4:08 PM ET 8-K
Financial Results Twilio Inc TWLO

Twilio Financial Results

Twilio reported Q3 2026 revenue of $1.56 billion, representing 20% year-over-year growth, driven by broad-based strength across its product portfolio. The company achieved GAAP net income of $1.00 per diluted share and generated $370 million in free cash flow during the quarter. Additionally, Twilio repurchased $127.2 million of its common stock as part of its ongoing $2.0 billion share repurchase program.

Term
Q3 2026

“Q3 was a great quarter for Twilio, driven by disciplined execution and broad-based strength across our product portfolio. Consumer AI has accelerated AI development, and its adoption demands fast, reliable infrastructure built for AI speed. Twilio is well positioned to capitalize on this moment and meet this demand.”

Khozema Shipchandler, CEO of Twilio
4:08 PM ET 8-K
Financial Results Edison International EIX

Edison International Financial Results

Edison International reported third-quarter 2026 GAAP EPS of $1.88 and core EPS of $1.92, while reaffirming its full-year 2026 core EPS guidance of $5.90 to $6.20. The company highlighted that its subsidiary, Southern California Edison, has hardened approximately 90% of its distribution system in high fire risk areas and continues to advocate for durable wildfire reform in California.

“Edison International posted another quarter of strong operational performance, with a focus on community safety and customer affordability. We continue advancing our efforts toward outcomes that serve customers, communities, and capital providers.”

Pedro J. Pizarro, president and CEO of Edison International

“California needs lasting wildfire reform to help protect customer affordability and support investment in a safer, more reliable grid. We are working with stakeholders toward a long-term solution that will enable the needed investments at a reasonable cost of capital.”

Pedro J. Pizarro, president and CEO of Edison International
4:08 PM ET 10-Q
Financial Results Hasbro, Inc. HAS

Hasbro Q3 2026 Results: Net Income $394M, Up 69.2% YoY

Hasbro, Inc. filed its Q3 2026 report highlighting its 'Playing to Win' strategy and a planned relocation of Rhode Island operations to Boston. The company is managing risks related to unauthorized network access, evolving AI regulations, and potential tariff impacts on its Magic: The Gathering and digital gaming segments.

Key figure
Net income $394M · +69.2% YoY
4:08 PM ET 10-Q
Financial Results Healthcare Realty Trust Inc HR

Healthcare Realty Trust Q3 2026 Results: Net Loss of $15.8M, Loss Narrows

Healthcare Realty Trust reported a net loss of $15.8 million for the third quarter of 2026, an improvement from a $58.5 million loss in the prior year period. Total assets decreased to $8.96 billion from $9.21 billion at year-end 2025, while the company continued its capital allocation strategy through common stock repurchases and dividend payments.

Key figure
Net loss $15.8M
4:08 PM ET 10-Q
Financial Results Climb Global Solutions, Inc. CLMB

Climb Global Solutions Q3 2026 Results: Net Income $7.94M, Up 69.0% YoY

Climb Global Solutions reported significant growth for the nine months ended September 30, 2026, with net sales increasing to $576.9 million from $458.7 million in the prior year. Net income rose to $16.8 million, driven by strong operational performance and a 19% increase in gross profit, despite higher selling, general, and administrative expenses.

Key figure
Net income $7.94M · +69.0% YoY
4:07 PM ET 10-Q
Financial Results XPO, Inc. XPO

XPO Q3 2026 Results: Net Income $181M, Up 120.7% YoY

XPO, Inc. reported a significant increase in net income for the third quarter of 2026, reaching $181 million compared to $82 million in the prior year period, driven by higher revenues of $2.37 billion. For the nine months ended September 30, 2026, the company generated $906 million in cash from operating activities and reduced its long-term debt to approximately $3.0 billion.

Key figure
Net income $181M · +120.7% YoY
4:07 PM ET 8-K
Financial Results Davita Inc. DVA

Davita Financial Results

DaVita Inc. reported Q3 2026 consolidated revenues of $3.578 billion and adjusted diluted EPS of $3.82. The company generated $519 million in operating cash flow and repurchased 0.6 million shares during the quarter at an average price of $186.21. Results were impacted by non-cash goodwill and asset impairment charges related to its business in China.

Term
Q3 2026
4:07 PM ET 8-K
Financial Results CarParts.com, Inc. PRTS

CarParts.com Financial Results

CarParts.com reported third quarter 2026 financial results, achieving its third consecutive quarter of positive Adjusted EBITDA at $1.0 million. Net sales grew 1.2% to $129.3 million, while net loss narrowed significantly to $4.1 million compared to $10.9 million in the prior year. The company highlighted growth in its A-Premium partnership and the launch of its new CarParts+ Rewards loyalty program.

Term
Q3 2026

“Q3 marks our third consecutive quarter of positive Adjusted EBITDA, and we grew net sales year over year while maintaining the advertising and pricing discipline we have applied all year. These results reflect deliberate decisions on assortment, footprint, pricing, advertising efficiency, and partnerships, executed consistently over time. They are structural, not one-time. We also know we are early. $1 million of Adjusted EBITDA is a foundation, and our focus now is building on it.”

David Meniane, Chief Executive Officer

“With our restructuring largely complete, the next phase is about growth. We recently launched CarParts+ Rewards, which has already enrolled more than 200,000 members. The same discipline that drove this year’s results will guide how we invest for growth.”

David Meniane, Chief Executive Officer
4:07 PM ET 10-Q
Financial Results Tenet Healthcare Corp THC

Tenet Healthcare Q3 2026 Results: Net Income $1.22B, Up 110.5% YoY

Tenet Healthcare reported a significant increase in net income to $3.17 billion for the nine months ended September 30, 2026, driven largely by $1.47 billion in revenue from contract terminations. The company also completed the redemption of Catholic Health Initiatives' minority interest in Conifer Health Solutions, resulting in Conifer becoming a wholly owned subsidiary.

Key figure
Net income $1.22B · +110.5% YoY
4:07 PM ET 10-Q
Financial Results First Solar, Inc. FSLR

First Solar Q3 2026 Results: Net Income $571M, Up 25.2% YoY

First Solar reported net income of $571.1 million for the third quarter of 2026, an increase from $455.9 million in the same period of 2025, despite a decrease in net sales to $1.23 billion. The company's balance sheet remains strong with total assets of $14.0 billion, though cash and cash equivalents decreased significantly to $1.58 billion as of September 30, 2026.

Key figure
Net income $571M · +25.2% YoY
4:07 PM ET 8-K
Financial Results Schneider National, Inc. SNDR

Schneider National Financial Results

Schneider National reported third quarter 2026 operating revenues of $1.6 billion and net income of $49.5 million, representing a significant year-over-year increase in profitability. The company raised its full-year 2026 adjusted diluted EPS guidance to a range of $1.00 - $1.10, citing improved operating leverage and a return to profitability in its Truckload Network segment.

Term
Q3 2026

“Our third-quarter performance demonstrates how our strategy has positioned the enterprise to convert improving market conditions into stronger earnings and margins. Disciplined revenue management, productivity gains, and cost reductions are improving our operating leverage, while our diversified multimodal platform gives us the agility to respond as customer needs and freight flows evolve.”

Jim Filter, President and Chief Executive Officer of Schneider

“Truckload earnings more than doubled year-over-year, reflecting Network’s return to profitability and continued progress on Dedicated portfolio actions. Intermodal delivered strong earnings growth supported by our differentiated offering and proactive price actions. While Logistics results were impacted by higher claim costs, the underlying business continued to improve including positive net revenue per order trends.”

Jim Filter, President and Chief Executive Officer of Schneider
4:07 PM ET 8-K
Financial Results Rimini Street, Inc. RMNI

Rimini Street Financial Results

Rimini Street reported Q3 2026 revenue of $112.1 million, an 8.3% increase year-over-year, and Adjusted EBITDA of $15.1 million. The company highlighted record sales for SAP software services and reiterated its fiscal 2026 'Rule of 20' guidance while completing $5.0 million in stock repurchases during the quarter.

Term
Q3 2026

“Our third-quarter results demonstrate three consecutive quarters of achievement against our fiscal 2026 plan and guidance provided at our December 2025 Investor Day, mark five consecutive quarters of improving financial and growth results and we are reiterating our fiscal 2026 ‘Rule of 20’ guidance.”

Seth Ravin, president and CEO, Rimini Street

“For the third quarter, we delivered top and bottom-line results that exceeded coverage analyst consensus and demonstrated increasing operating leverage in our business model.”

Michael Perica, CFO, Rimini Street
4:07 PM ET 10-Q
Financial Results Donnelley Financial Solutions, Inc. DFIN

Donnelley Financial Solutions Q3 2026 Results: Turns Profitable, Net Income $21.3M

Donnelley Financial Solutions reported net sales of $185.0 million for Q3 2026, a 5.5% increase year-over-year, driven by growth in software solutions and tech-enabled services. Net earnings improved significantly to $21.3 million compared to a net loss of $40.9 million in Q3 2025, which had been impacted by a $82.8 million pension plan settlement charge.

Key figure
Net income $21.3M
4:07 PM ET 10-Q
Financial Results AGNC Investment Corp. AGNC

AGNC Investment Q3 2026 Results: Net Loss of $1.36B

AGNC Investment Corp. reported a net loss of $1,357 million for the third quarter of 2026, primarily driven by $5,015 million in unrealized losses on investment securities. Despite the net loss, the company maintained its common dividend at $0.36 per share and increased its total assets to $133.4 billion from $115.1 billion at year-end 2025.

Key figure
Net loss $1.36B
4:07 PM ET 10-Q
Financial Results enVVeno Medical Corp NVNO

enVVeno Medical Q3 2026 Results: Net Loss of $4.37M, Loss Narrows

enVVeno Medical Corp reported a net loss of $11.8 million for the first nine months of 2026, an improvement from the $15.7 million loss in the prior year period. The company is transitioning into a pivotal U.S. clinical study for its enVVe System after receiving FDA IDE approval in April 2026.

Key figure
Net loss $4.37M
4:07 PM ET 8-K
Financial Results First Business Financial Services, Inc. FBIZ

First Business Financial Services Financial Results

First Business Financial Services reported record Q3 2026 net income of $16.4 million, or $1.95 per diluted share, driven by 10% annualized loan growth and strong net interest margins. The company also declared quarterly cash dividends for its common and preferred stock while achieving a 13.4% year-over-year increase in tangible book value per share.

Term
Q3 2026

“Our record third quarter results reflect strong execution across First Business Bank’s relationship-based model. Annualized loan growth of approximately 10% was more than fully funded by 14% annualized core deposit growth, while a strong net interest margin and disciplined expense management drove record pre-tax, pre-provision earnings.”

Dave Seiler, President and Chief Executive Officer

“We expect expenses to increase from the third-quarter level as we make planned investments in talent, marketing, technology, and infrastructure to support continued growth. These investments are integral to our long-term model of approximately 10% annual balance sheet growth and positive annual operating leverage.”

Dave Seiler, President and Chief Executive Officer
4:07 PM ET 8-K
Financial Results Resmed Inc RMD

Resmed Financial Results

ResMed reported Q1 fiscal year 2027 revenue of $1.4 billion, a 6% increase driven by global demand for sleep and breathing health solutions. The company returned over $1 billion to shareholders through dividends and share repurchases during the quarter, supported by strong free cash flow and the divestiture of MatrixCare.

Term
Q1 2027

“We began fiscal year 2027 with a strong first quarter, driven by continued global demand for our sleep and breathing health solutions and ongoing execution across our business. Year over year, we grew core constant currency revenue 7%, expanded non-GAAP gross margin by 50 basis points, and increased non-GAAP earnings per share by 14%.”

Mick Farrell, Resmed’s Chairman and CEO

“Looking ahead to the rest of fiscal year 2027, we will continue to build our core sleep and breathing health businesses by extending the reach of our digital health ecosystem and connecting more of the people worldwide who need care with life-saving treatment delivered right in their own home.”

Mick Farrell, Resmed’s Chairman and CEO
4:06 PM ET 8-K
Financial Results Healthcare Realty Trust Inc HR

Healthcare Realty Trust Financial Results

Healthcare Realty Trust reported Q3 2026 financial results, including a Normalized FFO of $0.42 per share and same-store cash NOI growth of 5.1%. The company increased its full-year 2026 Normalized FFO guidance to a range of $1.65 to $1.67 per share. Operational highlights include 1.5 million square feet of lease executions and $211 million in joint venture acquisitions with KKR.

4:06 PM ET 8-K
Financial Results Amazon Com Inc AMZN

Amazon Com Financial Results

Amazon reported third-quarter 2026 net sales of $201.9 billion, up 12% year-over-year, driven by 39% growth in its AWS segment. Operating income reached a record $28.1 billion with a 13.9% margin, though net income slightly decreased to $20.7 billion due to prior-year investment gains.

Term
Q3 2026

“Our AWS investment in functionality and infrastructure is working, with over 39% year-over-year revenue growth in Q3 ($184 billion revenue run rate) and projected revenue growth rates of over 40% both in 2027 and in 2028.”

Andy Jassy, President and CEO, Amazon

“Our broader selection and speedier delivery are helping us capture more retail market segment share with improving margins, and our newer businesses, ranging from Grocery to Pharmacy to Amazon Leo to Zoox are progressing encouragingly. There has never been a trillion dollar revenue business, and we may have two of them in the next 5-10 years.”

Andy Jassy, President and CEO, Amazon
4:06 PM ET 8-K
Financial Results Pure Bioscience, Inc. PURE

Pure Bioscience Financial Results

PURE Bioscience reported financial results for the fiscal year ended July 31, 2026, with net product sales increasing 5% to $2.3 million. The company posted a net loss of $2.5 million, or $0.02 per share, as growth in its end-user network was offset by a challenging macro environment and disruptions in the food industry.

Term
FY2026

“We are up year-over-year despite being a challenging year, with the macro environment causing increased expenses and foodborne outbreaks severely disrupting the food industry. Although our growth didn’t meet expectations, our focus remains on reducing costs and converting more opportunities into revenue.”

Jeff Kitchell, Chief Executive Officer
4:06 PM ET 10-Q
Financial Results Nwpx Infrastructure, Inc. NWPX

Nwpx Infrastructure Q3 2026 Results: Net Income $18.2M, Up 35.0% YoY

NWPX Infrastructure, Inc. reported strong growth for the third quarter of 2026, with net sales increasing to $179.4 million from $151.1 million in the prior year period. Net income rose significantly to $18.2 million, or $1.86 per diluted share, driven by higher gross profits and improved operating margins.

Key figure
Net income $18.2M · +35.0% YoY
4:06 PM ET 10-Q
Financial Results Penske Automotive Group, Inc. PAG

Penske Automotive Group Q3 2026 Results: Net Income $221M, Down 1.8% YoY

Penske Automotive Group reported total revenues of $8.4 billion for the third quarter of 2026, a 4.5% increase compared to the prior year. While net income attributable to common stockholders slightly decreased to $220.8 million ($3.36 per share), the company significantly expanded its footprint through $669.7 million in acquisitions during the first nine months of the year.

Key figure
Net income $221M · -1.8% YoY
4:06 PM ET 8-K
Financial Results Exponent Inc EXPO

Exponent Financial Results

Exponent reported third quarter 2026 financial results with total revenues increasing 18% to $173.7 million and net income rising to $30.9 million. The company saw strong demand for user research studies and reactive work in failure analysis across the chemical, consumer products, and transportation industries.

Term
Q3 2026

“Exponent delivered another strong quarter, with double-digit growth in revenues and earnings, reflecting continued demand for our specialized, integrated engineering and scientific expertise.”

Dr. Catherine Corrigan, Chief Executive Officer

“Our multidisciplinary scientists and engineers bring together deep domain expertise, scientific rigor, and an understanding of complex physical systems to help clients innovate with confidence, solve their most challenging problems, and manage high-consequence risk.”

Dr. Catherine Corrigan, Chief Executive Officer
4:06 PM ET 8-K
Financial Results Stoke Therapeutics, Inc. STOK

Stoke Therapeutics Financial Results

Stoke Therapeutics reported Q3 2026 financial results, highlighting a cash position of $358.8 million which is expected to fund operations into early 2028. The company provided clinical updates on its Phase 3 EMPEROR study for Dravet syndrome, with a data readout anticipated in Q3 2027 and a planned NDA submission in H2 2027.

Term
Q3 2026

“The Phase 3 EMPEROR study of zorevunersen continues to progress well. Approximately 110 of 162 enrolled patients have completed their Week 28 visit when the primary endpoint of change in major motor seizure frequency is measured and approximately 20 are through Week 52, the end of the treatment period. All 20 of these patients are continuing into the open-label extension period of the study and to date, no patients have discontinued treatment.”

Ian F. Smith, Chief Executive Officer and Director of Stoke Therapeutics

“Our second clinical program, STK-002, targets the protein haploinsufficiency that causes ADOA and therefore may have the potential to improve vision in people living with this severe genetic disease that often leads to blindness. Dosing in the first two cohorts is complete and dosing in the third cohort is underway with the fourth cohort expected to follow in early 2027.”

Ian F. Smith, Chief Executive Officer and Director of Stoke Therapeutics

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.